CD47 and nasopharyngeal carcinoma: Based on recent reports that miRNAs efficiently regulate immune responses as modulators of immune checkpoint molecules and their potential as cancer therapeutic targets and agents [17, 23, 24], it is reasonable to speculate that miRNAs could affect CD47 and exert associated effects on immune checkpoints during NPC tumorigenesis.